Invitation to Nanoform’s Q4 and FY2025 Report Presentation
Nanoform Finland Plc | Press Release | February 13, 2026…
Nanoform – Subcutaneously administered Nanotrastuzumab matches performance of Herceptin HYLECTA in minipig study
Nanoform Finland Plc | Press Release | February 12, 2026…